Cambridge Investment Research Advisors
HYLG

Cambridge Investment Research Advisors’s Global X Health Care Covered Call & Growth ETF HYLG Stock Holding History

Cambridge Investment Research Advisors’s Portfolio HYLG Stock Details HYLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,088
Closed -$215K – 3671
2024
Q4 		$215K Buy
9,088
+101
+1% +$2.54K ﹤0.01% 3137
2024
Q3 		$236K Buy
8,987
+336
+4% +$8.74K ﹤0.01% 3013
2024
Q2 		$219K Sell
8,651
-1,150
-12% -$28.9K ﹤0.01% 2960
2024
Q1 		$254K Buy
+9,801
New +$248K ﹤0.01% 2838

Cambridge Investment Research Advisors's HYLG Position: Q1 2025 in Review

Cambridge Investment Research Advisors sold out of Global X Health Care Covered Call & Growth ETF (HYLG) in Q1 2025, closing a stake of 9,088 shares — an estimated $215K sold.

Cambridge Investment Research Advisors first reported a position in HYLG in Q1 2024 and held it in 4 quarters. The position peaked at $254K in Q1 2024. 0 funds tracked by Wall St. Rank hold HYLG as of Q1 2025.

  • Cambridge Investment Research Advisors reported no remaining Global X Health Care Covered Call & Growth ETF position as of Q1 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 9,088 Global X Health Care Covered Call & Growth ETF shares in Q1 2025, an estimated $215K.
  • Cambridge Investment Research Advisors first reported a position in Global X Health Care Covered Call & Growth ETF in Q1 2024 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's Global X Health Care Covered Call & Growth ETF position peaked at $254K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Global X Health Care Covered Call & Growth ETF as of Q1 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.